Predicting the bioactive conformations of macrocycles: a molecular dynamics-based docking procedure with DynaDock

被引:0
作者
Ilke Ugur
Maja Schroft
Antoine Marion
Manuel Glaser
Iris Antes
机构
[1] Technische Universität München,Center for Integrated Protein Science at the Department for Biosciences
[2] Middle East Technical University,Department of Chemistry
来源
Journal of Molecular Modeling | 2019年 / 25卷
关键词
Macrocyclic compounds; Protein–ligand docking; Drug design; Conformational sampling; Molecular dynamics; DynaDock;
D O I
暂无
中图分类号
学科分类号
摘要
Macrocyclic compounds are of growing interest as a new class of therapeutics, especially as inhibitors binding to protein–protein interfaces. As molecular modeling is a well-established complimentary tool in modern drug design, the number of attempts to develop reliable docking strategies and algorithms to accurately predict the binding mode of macrocycles is rising continuously. Standard molecular docking approaches need to be adapted to this application, as a comprehensive yet efficient sampling of all ring conformations of the macrocycle is necessary. To overcome this issue, we designed a molecular dynamics-based docking protocol for macrocycles, in which the challenging sampling step is addressed by conventional molecular dynamics (750 ns) simulations performed at moderately high temperature (370 K). Consecutive flexible docking with the DynaDock approach based on multiple, pre-sampled ring conformations yields highly accurate poses with ligand RMSD values lower than 1.8 Å. We further investigated the value of molecular dynamics-based complex stability estimations for pose selection and discuss its applicability in combination with standard binding free energy estimations for assessing the quality of poses in future blind docking studies.
引用
收藏
相关论文
共 260 条
  • [1] Driggers EM(2008)The exploration of macrocycles for drug discovery--an underexploited structural class Nat Rev Drug Discov 7 608-624
  • [2] Hale SP(2014)Tools and rules for macrocycles Nat Chem Biol 10 696-698
  • [3] Lee J(2014)How proteins bind macrocycles Nat Chem Biol 10 723-731
  • [4] Terrett NK(2012)Macrocycles in new drug discovery Future Med. Chem. 4 1409-1438
  • [5] Heinis C(2015)Review cyclic peptides on a merry-go-round; towards drug design Biopolymers 104 453-461
  • [6] discovery D(2015)Biological targets and mechanisms of action of natural products from marine cyanobacteria Nat Prod Rep 32 478-503
  • [7] Villar EA(2011)Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery J Med Chem 54 1961-2004
  • [8] Beglov D(2017)Protein epitope mimetic macrocycles as biopharmaceuticals Curr Opin Chem Biol 38 45-51
  • [9] Chennamadhavuni S(2018)Constrained peptides’ time to shine? Nat Rev Drug Discov 17 531-533
  • [10] Porco JA(2012)Cyclic peptides as therapeutic agents and biochemical tools Biomol. Ther. 20 19-431